Global Alvimopan Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Alvimopan market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting ?-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.
Alvimopan (CAS 156053-89-3) is widely used in Pharmaceutical and Other field. The most proportion of Alvimopan (CAS 156053-89-3) is used in Pharmaceutical, and the proportion in 2019 is 88.64%. Market competition is intense. Merck is the leaders of the industry, and they hold key technologies and patents, with high-end customers.
LP Information, Inc. (LPI) ' newest research report, the “Alvimopan Industry Forecast” looks at past sales and reviews total world Alvimopan sales in 2024, providing a comprehensive analysis by region and market sector of projected Alvimopan sales for 2025 through 2031. With Alvimopan sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Alvimopan industry.
This Insight Report provides a comprehensive analysis of the global Alvimopan landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Alvimopan portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Alvimopan market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Alvimopan and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Alvimopan.
This report presents a comprehensive overview, market shares, and growth opportunities of Alvimopan market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Alvimopan market?
What factors are driving Alvimopan market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Alvimopan market opportunities vary by end market size?
How does Alvimopan break out by Type, by Application?
The global Alvimopan market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
Alvimopan, CAS 156053-89-3, (trade name Entereg) is a drug, which behaves as a peripherally acting ?-opioid receptor antagonist. It is currently only Food and Drug Administration approved for the treatment of postoperative ileus, which it received in May 2008.
Alvimopan (CAS 156053-89-3) is widely used in Pharmaceutical and Other field. The most proportion of Alvimopan (CAS 156053-89-3) is used in Pharmaceutical, and the proportion in 2019 is 88.64%. Market competition is intense. Merck is the leaders of the industry, and they hold key technologies and patents, with high-end customers.
LP Information, Inc. (LPI) ' newest research report, the “Alvimopan Industry Forecast” looks at past sales and reviews total world Alvimopan sales in 2024, providing a comprehensive analysis by region and market sector of projected Alvimopan sales for 2025 through 2031. With Alvimopan sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Alvimopan industry.
This Insight Report provides a comprehensive analysis of the global Alvimopan landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Alvimopan portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Alvimopan market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Alvimopan and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Alvimopan.
This report presents a comprehensive overview, market shares, and growth opportunities of Alvimopan market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Pharmaceutical Grade
- Others
- Pharmaceutical
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck
- Teva Pharmaceutical Industries Ltd
- MSN Life Sciences Private Ltd
What is the 10-year outlook for the global Alvimopan market?
What factors are driving Alvimopan market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Alvimopan market opportunities vary by end market size?
How does Alvimopan break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Alvimopan Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Alvimopan by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Alvimopan by Country/Region, 2020, 2024 & 2031
2.2 Alvimopan Segment by Type
2.2.1 Pharmaceutical Grade
2.2.2 Others
2.3 Alvimopan Sales by Type
2.3.1 Global Alvimopan Sales Market Share by Type (2020-2025)
2.3.2 Global Alvimopan Revenue and Market Share by Type (2020-2025)
2.3.3 Global Alvimopan Sale Price by Type (2020-2025)
2.4 Alvimopan Segment by Application
2.4.1 Pharmaceutical
2.4.2 Other
2.5 Alvimopan Sales by Application
2.5.1 Global Alvimopan Sale Market Share by Application (2020-2025)
2.5.2 Global Alvimopan Revenue and Market Share by Application (2020-2025)
2.5.3 Global Alvimopan Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Alvimopan Breakdown Data by Company
3.1.1 Global Alvimopan Annual Sales by Company (2020-2025)
3.1.2 Global Alvimopan Sales Market Share by Company (2020-2025)
3.2 Global Alvimopan Annual Revenue by Company (2020-2025)
3.2.1 Global Alvimopan Revenue by Company (2020-2025)
3.2.2 Global Alvimopan Revenue Market Share by Company (2020-2025)
3.3 Global Alvimopan Sale Price by Company
3.4 Key Manufacturers Alvimopan Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Alvimopan Product Location Distribution
3.4.2 Players Alvimopan Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ALVIMOPAN BY GEOGRAPHIC REGION
4.1 World Historic Alvimopan Market Size by Geographic Region (2020-2025)
4.1.1 Global Alvimopan Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Alvimopan Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Alvimopan Market Size by Country/Region (2020-2025)
4.2.1 Global Alvimopan Annual Sales by Country/Region (2020-2025)
4.2.2 Global Alvimopan Annual Revenue by Country/Region (2020-2025)
4.3 Americas Alvimopan Sales Growth
4.4 APAC Alvimopan Sales Growth
4.5 Europe Alvimopan Sales Growth
4.6 Middle East & Africa Alvimopan Sales Growth
5 AMERICAS
5.1 Americas Alvimopan Sales by Country
5.1.1 Americas Alvimopan Sales by Country (2020-2025)
5.1.2 Americas Alvimopan Revenue by Country (2020-2025)
5.2 Americas Alvimopan Sales by Type (2020-2025)
5.3 Americas Alvimopan Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alvimopan Sales by Region
6.1.1 APAC Alvimopan Sales by Region (2020-2025)
6.1.2 APAC Alvimopan Revenue by Region (2020-2025)
6.2 APAC Alvimopan Sales by Type (2020-2025)
6.3 APAC Alvimopan Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Alvimopan by Country
7.1.1 Europe Alvimopan Sales by Country (2020-2025)
7.1.2 Europe Alvimopan Revenue by Country (2020-2025)
7.2 Europe Alvimopan Sales by Type (2020-2025)
7.3 Europe Alvimopan Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Alvimopan by Country
8.1.1 Middle East & Africa Alvimopan Sales by Country (2020-2025)
8.1.2 Middle East & Africa Alvimopan Revenue by Country (2020-2025)
8.2 Middle East & Africa Alvimopan Sales by Type (2020-2025)
8.3 Middle East & Africa Alvimopan Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Alvimopan
10.3 Manufacturing Process Analysis of Alvimopan
10.4 Industry Chain Structure of Alvimopan
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Alvimopan Distributors
11.3 Alvimopan Customer
12 WORLD FORECAST REVIEW FOR ALVIMOPAN BY GEOGRAPHIC REGION
12.1 Global Alvimopan Market Size Forecast by Region
12.1.1 Global Alvimopan Forecast by Region (2026-2031)
12.1.2 Global Alvimopan Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Alvimopan Forecast by Type (2026-2031)
12.7 Global Alvimopan Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Alvimopan Product Portfolios and Specifications
13.1.3 Merck Alvimopan Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Teva Pharmaceutical Industries Ltd
13.2.1 Teva Pharmaceutical Industries Ltd Company Information
13.2.2 Teva Pharmaceutical Industries Ltd Alvimopan Product Portfolios and Specifications
13.2.3 Teva Pharmaceutical Industries Ltd Alvimopan Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.2.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.3 MSN Life Sciences Private Ltd
13.3.1 MSN Life Sciences Private Ltd Company Information
13.3.2 MSN Life Sciences Private Ltd Alvimopan Product Portfolios and Specifications
13.3.3 MSN Life Sciences Private Ltd Alvimopan Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 MSN Life Sciences Private Ltd Main Business Overview
13.3.5 MSN Life Sciences Private Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Alvimopan Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Alvimopan Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Pharmaceutical Grade
Table 4. Major Players of Others
Table 5. Global Alvimopan Sales byType (2020-2025) & (KG)
Table 6. Global Alvimopan Sales Market Share byType (2020-2025)
Table 7. Global Alvimopan Revenue byType (2020-2025) & ($ million)
Table 8. Global Alvimopan Revenue Market Share byType (2020-2025)
Table 9. Global Alvimopan Sale Price byType (2020-2025) & (US$/g)
Table 10. Global Alvimopan Sale by Application (2020-2025) & (KG)
Table 11. Global Alvimopan Sale Market Share by Application (2020-2025)
Table 12. Global Alvimopan Revenue by Application (2020-2025) & ($ million)
Table 13. Global Alvimopan Revenue Market Share by Application (2020-2025)
Table 14. Global Alvimopan Sale Price by Application (2020-2025) & (US$/g)
Table 15. Global Alvimopan Sales by Company (2020-2025) & (KG)
Table 16. Global Alvimopan Sales Market Share by Company (2020-2025)
Table 17. Global Alvimopan Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Alvimopan Revenue Market Share by Company (2020-2025)
Table 19. Global Alvimopan Sale Price by Company (2020-2025) & (US$/g)
Table 20. Key Manufacturers Alvimopan Producing Area Distribution and Sales Area
Table 21. Players Alvimopan Products Offered
Table 22. Alvimopan Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Alvimopan Sales by Geographic Region (2020-2025) & (KG)
Table 26. Global Alvimopan Sales Market Share Geographic Region (2020-2025)
Table 27. Global Alvimopan Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Alvimopan Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Alvimopan Sales by Country/Region (2020-2025) & (KG)
Table 30. Global Alvimopan Sales Market Share by Country/Region (2020-2025)
Table 31. Global Alvimopan Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Alvimopan Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Alvimopan Sales by Country (2020-2025) & (KG)
Table 34. Americas Alvimopan Sales Market Share by Country (2020-2025)
Table 35. Americas Alvimopan Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Alvimopan Sales byType (2020-2025) & (KG)
Table 37. Americas Alvimopan Sales by Application (2020-2025) & (KG)
Table 38. APAC Alvimopan Sales by Region (2020-2025) & (KG)
Table 39. APAC Alvimopan Sales Market Share by Region (2020-2025)
Table 40. APAC Alvimopan Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Alvimopan Sales byType (2020-2025) & (KG)
Table 42. APAC Alvimopan Sales by Application (2020-2025) & (KG)
Table 43. Europe Alvimopan Sales by Country (2020-2025) & (KG)
Table 44. Europe Alvimopan Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Alvimopan Sales byType (2020-2025) & (KG)
Table 46. Europe Alvimopan Sales by Application (2020-2025) & (KG)
Table 47. Middle East & Africa Alvimopan Sales by Country (2020-2025) & (KG)
Table 48. Middle East & Africa Alvimopan Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Alvimopan Sales byType (2020-2025) & (KG)
Table 50. Middle East & Africa Alvimopan Sales by Application (2020-2025) & (KG)
Table 51. Key Market Drivers & Growth Opportunities of Alvimopan
Table 52. Key Market Challenges & Risks of Alvimopan
Table 53. Key IndustryTrends of Alvimopan
Table 54. Alvimopan Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Alvimopan Distributors List
Table 57. Alvimopan Customer List
Table 58. Global Alvimopan SalesForecast by Region (2026-2031) & (KG)
Table 59. Global Alvimopan RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Alvimopan SalesForecast by Country (2026-2031) & (KG)
Table 61. Americas Alvimopan Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Alvimopan SalesForecast by Region (2026-2031) & (KG)
Table 63. APAC Alvimopan Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Alvimopan SalesForecast by Country (2026-2031) & (KG)
Table 65. Europe Alvimopan RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Alvimopan SalesForecast by Country (2026-2031) & (KG)
Table 67. Middle East & Africa Alvimopan RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Alvimopan SalesForecast byType (2026-2031) & (KG)
Table 69. Global Alvimopan RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Alvimopan SalesForecast by Application (2026-2031) & (KG)
Table 71. Global Alvimopan RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Merck Basic Information, Alvimopan Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Alvimopan Product Portfolios and Specifications
Table 74. Merck Alvimopan Sales (KG), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77.Teva Pharmaceutical Industries Ltd Basic Information, Alvimopan Manufacturing Base, Sales Area and Its Competitors
Table 78.Teva Pharmaceutical Industries Ltd Alvimopan Product Portfolios and Specifications
Table 79.Teva Pharmaceutical Industries Ltd Alvimopan Sales (KG), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 80.Teva Pharmaceutical Industries Ltd Main Business
Table 81.Teva Pharmaceutical Industries Ltd Latest Developments
Table 82. MSN Life Sciences Private Ltd Basic Information, Alvimopan Manufacturing Base, Sales Area and Its Competitors
Table 83. MSN Life Sciences Private Ltd Alvimopan Product Portfolios and Specifications
Table 84. MSN Life Sciences Private Ltd Alvimopan Sales (KG), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 85. MSN Life Sciences Private Ltd Main Business
Table 86. MSN Life Sciences Private Ltd Latest Developments
LIST OFFIGURES
Figure 1. Picture of Alvimopan
Figure 2. Alvimopan Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Alvimopan Sales Growth Rate 2020-2031 (KG)
Figure 7. Global Alvimopan Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Alvimopan Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Alvimopan Sales Market Share by Country/Region (2024)
Figure 10. Alvimopan Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Pharmaceutical Grade
Figure 12. Product Picture of Others
Figure 13. Global Alvimopan Sales Market Share byType in 2025
Figure 14. Global Alvimopan Revenue Market Share byType (2020-2025)
Figure 15. Alvimopan Consumed in Pharmaceutical
Figure 16. Global Alvimopan Market: Pharmaceutical (2020-2025) & (KG)
Figure 17. Alvimopan Consumed in Other
Figure 18. Global Alvimopan Market: Other (2020-2025) & (KG)
Figure 19. Global Alvimopan Sale Market Share by Application (2024)
Figure 20. Global Alvimopan Revenue Market Share by Application in 2025
Figure 21. Alvimopan Sales by Company in 2025 (KG)
Figure 22. Global Alvimopan Sales Market Share by Company in 2025
Figure 23. Alvimopan Revenue by Company in 2025 ($ millions)
Figure 24. Global Alvimopan Revenue Market Share by Company in 2025
Figure 25. Global Alvimopan Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Alvimopan Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Alvimopan Sales 2020-2025 (KG)
Figure 28. Americas Alvimopan Revenue 2020-2025 ($ millions)
Figure 29. APAC Alvimopan Sales 2020-2025 (KG)
Figure 30. APAC Alvimopan Revenue 2020-2025 ($ millions)
Figure 31. Europe Alvimopan Sales 2020-2025 (KG)
Figure 32. Europe Alvimopan Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Alvimopan Sales 2020-2025 (KG)
Figure 34. Middle East & Africa Alvimopan Revenue 2020-2025 ($ millions)
Figure 35. Americas Alvimopan Sales Market Share by Country in 2025
Figure 36. Americas Alvimopan Revenue Market Share by Country (2020-2025)
Figure 37. Americas Alvimopan Sales Market Share byType (2020-2025)
Figure 38. Americas Alvimopan Sales Market Share by Application (2020-2025)
Figure 39. United States Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Alvimopan Sales Market Share by Region in 2025
Figure 44. APAC Alvimopan Revenue Market Share by Region (2020-2025)
Figure 45. APAC Alvimopan Sales Market Share byType (2020-2025)
Figure 46. APAC Alvimopan Sales Market Share by Application (2020-2025)
Figure 47. China Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 51. India Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Alvimopan Sales Market Share by Country in 2025
Figure 55. Europe Alvimopan Revenue Market Share by Country (2020-2025)
Figure 56. Europe Alvimopan Sales Market Share byType (2020-2025)
Figure 57. Europe Alvimopan Sales Market Share by Application (2020-2025)
Figure 58. Germany Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 59.France Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Alvimopan Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Alvimopan Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Alvimopan Sales Market Share by Application (2020-2025)
Figure 66. Egypt Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Alvimopan in 2025
Figure 72. Manufacturing Process Analysis of Alvimopan
Figure 73. Industry Chain Structure of Alvimopan
Figure 74. Channels of Distribution
Figure 75. Global Alvimopan Sales MarketForecast by Region (2026-2031)
Figure 76. Global Alvimopan Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Alvimopan Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Alvimopan Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Alvimopan Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Alvimopan Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Alvimopan Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Alvimopan by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Alvimopan by Country/Region, 2020, 2024 & 2031
2.2 Alvimopan Segment by Type
2.2.1 Pharmaceutical Grade
2.2.2 Others
2.3 Alvimopan Sales by Type
2.3.1 Global Alvimopan Sales Market Share by Type (2020-2025)
2.3.2 Global Alvimopan Revenue and Market Share by Type (2020-2025)
2.3.3 Global Alvimopan Sale Price by Type (2020-2025)
2.4 Alvimopan Segment by Application
2.4.1 Pharmaceutical
2.4.2 Other
2.5 Alvimopan Sales by Application
2.5.1 Global Alvimopan Sale Market Share by Application (2020-2025)
2.5.2 Global Alvimopan Revenue and Market Share by Application (2020-2025)
2.5.3 Global Alvimopan Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Alvimopan Breakdown Data by Company
3.1.1 Global Alvimopan Annual Sales by Company (2020-2025)
3.1.2 Global Alvimopan Sales Market Share by Company (2020-2025)
3.2 Global Alvimopan Annual Revenue by Company (2020-2025)
3.2.1 Global Alvimopan Revenue by Company (2020-2025)
3.2.2 Global Alvimopan Revenue Market Share by Company (2020-2025)
3.3 Global Alvimopan Sale Price by Company
3.4 Key Manufacturers Alvimopan Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Alvimopan Product Location Distribution
3.4.2 Players Alvimopan Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ALVIMOPAN BY GEOGRAPHIC REGION
4.1 World Historic Alvimopan Market Size by Geographic Region (2020-2025)
4.1.1 Global Alvimopan Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Alvimopan Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Alvimopan Market Size by Country/Region (2020-2025)
4.2.1 Global Alvimopan Annual Sales by Country/Region (2020-2025)
4.2.2 Global Alvimopan Annual Revenue by Country/Region (2020-2025)
4.3 Americas Alvimopan Sales Growth
4.4 APAC Alvimopan Sales Growth
4.5 Europe Alvimopan Sales Growth
4.6 Middle East & Africa Alvimopan Sales Growth
5 AMERICAS
5.1 Americas Alvimopan Sales by Country
5.1.1 Americas Alvimopan Sales by Country (2020-2025)
5.1.2 Americas Alvimopan Revenue by Country (2020-2025)
5.2 Americas Alvimopan Sales by Type (2020-2025)
5.3 Americas Alvimopan Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alvimopan Sales by Region
6.1.1 APAC Alvimopan Sales by Region (2020-2025)
6.1.2 APAC Alvimopan Revenue by Region (2020-2025)
6.2 APAC Alvimopan Sales by Type (2020-2025)
6.3 APAC Alvimopan Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Alvimopan by Country
7.1.1 Europe Alvimopan Sales by Country (2020-2025)
7.1.2 Europe Alvimopan Revenue by Country (2020-2025)
7.2 Europe Alvimopan Sales by Type (2020-2025)
7.3 Europe Alvimopan Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Alvimopan by Country
8.1.1 Middle East & Africa Alvimopan Sales by Country (2020-2025)
8.1.2 Middle East & Africa Alvimopan Revenue by Country (2020-2025)
8.2 Middle East & Africa Alvimopan Sales by Type (2020-2025)
8.3 Middle East & Africa Alvimopan Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Alvimopan
10.3 Manufacturing Process Analysis of Alvimopan
10.4 Industry Chain Structure of Alvimopan
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Alvimopan Distributors
11.3 Alvimopan Customer
12 WORLD FORECAST REVIEW FOR ALVIMOPAN BY GEOGRAPHIC REGION
12.1 Global Alvimopan Market Size Forecast by Region
12.1.1 Global Alvimopan Forecast by Region (2026-2031)
12.1.2 Global Alvimopan Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Alvimopan Forecast by Type (2026-2031)
12.7 Global Alvimopan Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Merck
13.1.1 Merck Company Information
13.1.2 Merck Alvimopan Product Portfolios and Specifications
13.1.3 Merck Alvimopan Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Merck Main Business Overview
13.1.5 Merck Latest Developments
13.2 Teva Pharmaceutical Industries Ltd
13.2.1 Teva Pharmaceutical Industries Ltd Company Information
13.2.2 Teva Pharmaceutical Industries Ltd Alvimopan Product Portfolios and Specifications
13.2.3 Teva Pharmaceutical Industries Ltd Alvimopan Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.2.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.3 MSN Life Sciences Private Ltd
13.3.1 MSN Life Sciences Private Ltd Company Information
13.3.2 MSN Life Sciences Private Ltd Alvimopan Product Portfolios and Specifications
13.3.3 MSN Life Sciences Private Ltd Alvimopan Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 MSN Life Sciences Private Ltd Main Business Overview
13.3.5 MSN Life Sciences Private Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Alvimopan Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Alvimopan Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Pharmaceutical Grade
Table 4. Major Players of Others
Table 5. Global Alvimopan Sales byType (2020-2025) & (KG)
Table 6. Global Alvimopan Sales Market Share byType (2020-2025)
Table 7. Global Alvimopan Revenue byType (2020-2025) & ($ million)
Table 8. Global Alvimopan Revenue Market Share byType (2020-2025)
Table 9. Global Alvimopan Sale Price byType (2020-2025) & (US$/g)
Table 10. Global Alvimopan Sale by Application (2020-2025) & (KG)
Table 11. Global Alvimopan Sale Market Share by Application (2020-2025)
Table 12. Global Alvimopan Revenue by Application (2020-2025) & ($ million)
Table 13. Global Alvimopan Revenue Market Share by Application (2020-2025)
Table 14. Global Alvimopan Sale Price by Application (2020-2025) & (US$/g)
Table 15. Global Alvimopan Sales by Company (2020-2025) & (KG)
Table 16. Global Alvimopan Sales Market Share by Company (2020-2025)
Table 17. Global Alvimopan Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Alvimopan Revenue Market Share by Company (2020-2025)
Table 19. Global Alvimopan Sale Price by Company (2020-2025) & (US$/g)
Table 20. Key Manufacturers Alvimopan Producing Area Distribution and Sales Area
Table 21. Players Alvimopan Products Offered
Table 22. Alvimopan Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Alvimopan Sales by Geographic Region (2020-2025) & (KG)
Table 26. Global Alvimopan Sales Market Share Geographic Region (2020-2025)
Table 27. Global Alvimopan Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Alvimopan Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Alvimopan Sales by Country/Region (2020-2025) & (KG)
Table 30. Global Alvimopan Sales Market Share by Country/Region (2020-2025)
Table 31. Global Alvimopan Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Alvimopan Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Alvimopan Sales by Country (2020-2025) & (KG)
Table 34. Americas Alvimopan Sales Market Share by Country (2020-2025)
Table 35. Americas Alvimopan Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Alvimopan Sales byType (2020-2025) & (KG)
Table 37. Americas Alvimopan Sales by Application (2020-2025) & (KG)
Table 38. APAC Alvimopan Sales by Region (2020-2025) & (KG)
Table 39. APAC Alvimopan Sales Market Share by Region (2020-2025)
Table 40. APAC Alvimopan Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Alvimopan Sales byType (2020-2025) & (KG)
Table 42. APAC Alvimopan Sales by Application (2020-2025) & (KG)
Table 43. Europe Alvimopan Sales by Country (2020-2025) & (KG)
Table 44. Europe Alvimopan Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Alvimopan Sales byType (2020-2025) & (KG)
Table 46. Europe Alvimopan Sales by Application (2020-2025) & (KG)
Table 47. Middle East & Africa Alvimopan Sales by Country (2020-2025) & (KG)
Table 48. Middle East & Africa Alvimopan Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Alvimopan Sales byType (2020-2025) & (KG)
Table 50. Middle East & Africa Alvimopan Sales by Application (2020-2025) & (KG)
Table 51. Key Market Drivers & Growth Opportunities of Alvimopan
Table 52. Key Market Challenges & Risks of Alvimopan
Table 53. Key IndustryTrends of Alvimopan
Table 54. Alvimopan Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Alvimopan Distributors List
Table 57. Alvimopan Customer List
Table 58. Global Alvimopan SalesForecast by Region (2026-2031) & (KG)
Table 59. Global Alvimopan RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Alvimopan SalesForecast by Country (2026-2031) & (KG)
Table 61. Americas Alvimopan Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Alvimopan SalesForecast by Region (2026-2031) & (KG)
Table 63. APAC Alvimopan Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Alvimopan SalesForecast by Country (2026-2031) & (KG)
Table 65. Europe Alvimopan RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Alvimopan SalesForecast by Country (2026-2031) & (KG)
Table 67. Middle East & Africa Alvimopan RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Alvimopan SalesForecast byType (2026-2031) & (KG)
Table 69. Global Alvimopan RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Alvimopan SalesForecast by Application (2026-2031) & (KG)
Table 71. Global Alvimopan RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. Merck Basic Information, Alvimopan Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Alvimopan Product Portfolios and Specifications
Table 74. Merck Alvimopan Sales (KG), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 75. Merck Main Business
Table 76. Merck Latest Developments
Table 77.Teva Pharmaceutical Industries Ltd Basic Information, Alvimopan Manufacturing Base, Sales Area and Its Competitors
Table 78.Teva Pharmaceutical Industries Ltd Alvimopan Product Portfolios and Specifications
Table 79.Teva Pharmaceutical Industries Ltd Alvimopan Sales (KG), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 80.Teva Pharmaceutical Industries Ltd Main Business
Table 81.Teva Pharmaceutical Industries Ltd Latest Developments
Table 82. MSN Life Sciences Private Ltd Basic Information, Alvimopan Manufacturing Base, Sales Area and Its Competitors
Table 83. MSN Life Sciences Private Ltd Alvimopan Product Portfolios and Specifications
Table 84. MSN Life Sciences Private Ltd Alvimopan Sales (KG), Revenue ($ Million), Price (US$/g) and Gross Margin (2020-2025)
Table 85. MSN Life Sciences Private Ltd Main Business
Table 86. MSN Life Sciences Private Ltd Latest Developments
LIST OFFIGURES
Figure 1. Picture of Alvimopan
Figure 2. Alvimopan Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Alvimopan Sales Growth Rate 2020-2031 (KG)
Figure 7. Global Alvimopan Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Alvimopan Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Alvimopan Sales Market Share by Country/Region (2024)
Figure 10. Alvimopan Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Pharmaceutical Grade
Figure 12. Product Picture of Others
Figure 13. Global Alvimopan Sales Market Share byType in 2025
Figure 14. Global Alvimopan Revenue Market Share byType (2020-2025)
Figure 15. Alvimopan Consumed in Pharmaceutical
Figure 16. Global Alvimopan Market: Pharmaceutical (2020-2025) & (KG)
Figure 17. Alvimopan Consumed in Other
Figure 18. Global Alvimopan Market: Other (2020-2025) & (KG)
Figure 19. Global Alvimopan Sale Market Share by Application (2024)
Figure 20. Global Alvimopan Revenue Market Share by Application in 2025
Figure 21. Alvimopan Sales by Company in 2025 (KG)
Figure 22. Global Alvimopan Sales Market Share by Company in 2025
Figure 23. Alvimopan Revenue by Company in 2025 ($ millions)
Figure 24. Global Alvimopan Revenue Market Share by Company in 2025
Figure 25. Global Alvimopan Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Alvimopan Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Alvimopan Sales 2020-2025 (KG)
Figure 28. Americas Alvimopan Revenue 2020-2025 ($ millions)
Figure 29. APAC Alvimopan Sales 2020-2025 (KG)
Figure 30. APAC Alvimopan Revenue 2020-2025 ($ millions)
Figure 31. Europe Alvimopan Sales 2020-2025 (KG)
Figure 32. Europe Alvimopan Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Alvimopan Sales 2020-2025 (KG)
Figure 34. Middle East & Africa Alvimopan Revenue 2020-2025 ($ millions)
Figure 35. Americas Alvimopan Sales Market Share by Country in 2025
Figure 36. Americas Alvimopan Revenue Market Share by Country (2020-2025)
Figure 37. Americas Alvimopan Sales Market Share byType (2020-2025)
Figure 38. Americas Alvimopan Sales Market Share by Application (2020-2025)
Figure 39. United States Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Alvimopan Sales Market Share by Region in 2025
Figure 44. APAC Alvimopan Revenue Market Share by Region (2020-2025)
Figure 45. APAC Alvimopan Sales Market Share byType (2020-2025)
Figure 46. APAC Alvimopan Sales Market Share by Application (2020-2025)
Figure 47. China Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 51. India Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 53. ChinaTaiwan Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Alvimopan Sales Market Share by Country in 2025
Figure 55. Europe Alvimopan Revenue Market Share by Country (2020-2025)
Figure 56. Europe Alvimopan Sales Market Share byType (2020-2025)
Figure 57. Europe Alvimopan Sales Market Share by Application (2020-2025)
Figure 58. Germany Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 59.France Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Alvimopan Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Alvimopan Sales Market Share byType (2020-2025)
Figure 65. Middle East & Africa Alvimopan Sales Market Share by Application (2020-2025)
Figure 66. Egypt Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 69.Turkey Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Alvimopan Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Alvimopan in 2025
Figure 72. Manufacturing Process Analysis of Alvimopan
Figure 73. Industry Chain Structure of Alvimopan
Figure 74. Channels of Distribution
Figure 75. Global Alvimopan Sales MarketForecast by Region (2026-2031)
Figure 76. Global Alvimopan Revenue Market ShareForecast by Region (2026-2031)
Figure 77. Global Alvimopan Sales Market ShareForecast byType (2026-2031)
Figure 78. Global Alvimopan Revenue Market ShareForecast byType (2026-2031)
Figure 79. Global Alvimopan Sales Market ShareForecast by Application (2026-2031)
Figure 80. Global Alvimopan Revenue Market ShareForecast by Application (2026-2031)
